EdgarLookup

RAYMOND JAMES FINANCIAL INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that RAYMOND JAMES FINANCIAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
13.4%
Profit Margin
Net income ÷ revenue
2.4%
Return on Assets
Net income ÷ assets
6.06x
Debt-to-Equity
Total liabilities ÷ equity
+6.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $15.91B Nov 25, 2025
FY2025 Sep 30, 2024 $14.92B Nov 25, 2025
FY2025 Sep 30, 2023 $12.99B Nov 25, 2025
FY2024 Sep 30, 2022 $11.31B Nov 26, 2024
FY2023 Sep 30, 2021 $9.91B Nov 21, 2023
FY2022 Sep 30, 2020 $8.17B Nov 22, 2022
FY2021 Sep 30, 2019 $8.02B Nov 23, 2021
FY2020 Sep 30, 2018 $7.48B Nov 24, 2020
FY2019 Sep 30, 2017 $6.53B Nov 26, 2019
FY2018 Sep 30, 2016 $5.52B Nov 21, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $2.14B Nov 25, 2025
FY2025 Sep 30, 2024 $2.07B Nov 25, 2025
FY2025 Sep 30, 2023 $1.74B Nov 25, 2025
FY2024 Sep 30, 2022 $1.51B Nov 26, 2024
FY2023 Sep 30, 2021 $1.40B Nov 21, 2023
FY2022 Sep 30, 2020 $818.00M Nov 22, 2022
FY2021 Sep 30, 2019 $1.03B Nov 23, 2021
FY2020 Sep 30, 2018 $857.00M Nov 24, 2020
FY2019 Sep 30, 2017 $636.00M Nov 26, 2019
FY2018 Sep 30, 2016 $529.35M Nov 21, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $2.43B Nov 25, 2025
FY2025 Sep 30, 2024 $2.16B Nov 25, 2025
FY2025 Sep 30, 2023 ($3.51B) Nov 25, 2025
FY2024 Sep 30, 2022 $72.00M Nov 26, 2024
FY2023 Sep 30, 2021 $6.65B Nov 21, 2023
FY2022 Sep 30, 2020 $4.07B Nov 22, 2022
FY2021 Sep 30, 2019 $577.00M Nov 23, 2021
FY2020 Sep 30, 2018 $884.00M Nov 24, 2020
FY2019 Sep 30, 2017 ($125.00M) Nov 26, 2019
FY2018 Sep 30, 2016 ($573.32M) Nov 21, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $188.00M Nov 25, 2025
FY2025 Sep 30, 2024 $205.00M Nov 25, 2025
FY2025 Sep 30, 2023 $173.00M Nov 25, 2025
FY2024 Sep 30, 2022 $91.00M Nov 26, 2024
FY2023 Sep 30, 2021 $74.00M Nov 21, 2023
FY2022 Sep 30, 2020 $124.00M Nov 22, 2022
FY2021 Sep 30, 2019 $138.00M Nov 23, 2021
FY2020 Sep 30, 2018 $134.00M Nov 24, 2020
FY2019 Sep 30, 2017 $190.00M Nov 26, 2019
FY2018 Sep 30, 2016 $121.73M Nov 21, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $88.23B Nov 25, 2025
FY2025 Sep 30, 2024 $82.99B Nov 25, 2025
FY2024 Sep 30, 2023 $78.36B Nov 26, 2024
FY2023 Sep 30, 2022 $80.95B Nov 21, 2023
FY2022 Sep 30, 2021 $61.89B Nov 22, 2022
FY2021 Sep 30, 2020 $47.48B Nov 23, 2021
FY2020 Sep 30, 2019 $38.83B Nov 24, 2020
FY2019 Sep 30, 2018 $37.41B Nov 26, 2019
FY2018 Sep 30, 2017 $34.88B Nov 21, 2018
FY2017 Sep 30, 2016 $31.49B Nov 22, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $75.73B Nov 25, 2025
FY2025 Sep 30, 2024 $71.33B Nov 25, 2025
FY2024 Sep 30, 2023 $68.17B Nov 26, 2024
FY2023 Sep 30, 2022 $71.52B Nov 21, 2023
FY2022 Sep 30, 2021 $53.59B Nov 22, 2022
FY2021 Sep 30, 2020 $40.31B Nov 23, 2021
FY2020 Sep 30, 2019 $32.19B Nov 24, 2020
FY2019 Sep 30, 2018 $30.96B Nov 26, 2019
FY2018 Sep 30, 2017 $29.19B Nov 21, 2018
FY2017 Sep 30, 2016 $26.42B Nov 22, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $12.50B Nov 25, 2025
FY2025 Sep 30, 2024 $11.67B Nov 25, 2025
FY2024 Sep 30, 2023 $10.21B Nov 26, 2024
FY2023 Sep 30, 2022 $9.46B Nov 21, 2023
FY2022 Sep 30, 2021 $8.25B Nov 22, 2022
FY2021 Sep 30, 2020 $7.11B Nov 23, 2021
FY2020 Sep 30, 2019 $6.58B Nov 24, 2020
FY2019 Sep 30, 2018 $6.37B Nov 26, 2019
FY2018 Sep 30, 2017 $5.58B Nov 21, 2018
FY2017 Sep 30, 2016 $4.92B Nov 22, 2017

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $1.45B Nov 25, 2025
FY2025 Sep 30, 2024 $1.45B Nov 25, 2025
FY2025 Sep 30, 2023 $1.44B Nov 25, 2025
FY2024 Sep 30, 2022 $1.42B Nov 26, 2024
FY2023 Sep 30, 2021 $660.00M Nov 21, 2023
FY2022 Sep 30, 2020 $466.00M Nov 22, 2022
FY2021 Sep 30, 2019 $464.00M Nov 23, 2021
FY2020 Sep 30, 2018 $478.00M Nov 24, 2020
FY2019 Sep 30, 2017 $411.00M Nov 26, 2019
FY2018 Sep 30, 2016 $408.07M Nov 21, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $13.60B Nov 25, 2025
FY2025 Sep 30, 2024 $11.89B Nov 25, 2025
FY2024 Sep 30, 2023 $10.21B Nov 26, 2024
FY2023 Sep 30, 2022 $8.84B Nov 21, 2023
FY2022 Sep 30, 2021 $7.63B Nov 22, 2022
FY2021 Sep 30, 2020 $6.48B Nov 23, 2021
FY2020 Sep 30, 2019 $5.87B Nov 24, 2020
FY2019 Sep 30, 2018 $5.03B Nov 26, 2019
FY2018 Sep 30, 2017 $4.34B Nov 21, 2018
FY2017 Sep 30, 2016 $3.83B Nov 22, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $11.39B Nov 25, 2025
FY2025 Sep 30, 2024 $11.00B Nov 25, 2025
FY2025 Sep 30, 2023 $9.31B Nov 25, 2025
FY2024 Sep 30, 2022 $6.18B Nov 26, 2024
FY2023 Sep 30, 2021 $7.20B Nov 21, 2023
FY2022 Sep 30, 2020 $5.39B Nov 22, 2022
FY2021 Sep 30, 2019 $3.96B Nov 23, 2021
FY2020 Sep 30, 2018 $3.50B Nov 24, 2020
FY2019 Sep 30, 2017 $3.67B Nov 26, 2019
FY2018 Sep 30, 2016 $1.65B Nov 21, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2014 Sep 30, 2014 $1.19B Nov 25, 2014
FY2014 Sep 30, 2013 $1.19B Nov 25, 2014

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 10 Nov 25, 2025
FY2025 Sep 30, 2024 9 Nov 25, 2025
FY2025 Sep 30, 2023 8 Nov 25, 2025
FY2024 Sep 30, 2022 7 Nov 26, 2024
FY2023 Sep 30, 2021 6 Nov 21, 2023
FY2022 Sep 30, 2020 3 Nov 22, 2022
FY2021 Sep 30, 2019 4 Nov 23, 2021
FY2020 Sep 30, 2018 5 Nov 24, 2020
FY2019 Sep 30, 2017 4 Nov 26, 2019
FY2018 Sep 30, 2016 3 Nov 21, 2018

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 10 Nov 25, 2025
FY2025 Sep 30, 2024 9 Nov 25, 2025
FY2025 Sep 30, 2023 7 Nov 25, 2025
FY2024 Sep 30, 2022 6 Nov 26, 2024
FY2023 Sep 30, 2021 6 Nov 21, 2023
FY2022 Sep 30, 2020 3 Nov 22, 2022
FY2021 Sep 30, 2019 4 Nov 23, 2021
FY2020 Sep 30, 2018 5 Nov 24, 2020
FY2019 Sep 30, 2017 4 Nov 26, 2019
FY2018 Sep 30, 2016 3 Nov 21, 2018

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 198.14M Nov 25, 2025
FY2025 Sep 30, 2024 203.29M Nov 25, 2025
FY2025 Sep 30, 2023 208.80M Nov 25, 2025
FY2025 Sep 30, 2022 215.10M Nov 25, 2025
FY2024 Sep 30, 2021 205.70M Nov 26, 2024
FY2023 Sep 30, 2020 204.90M Nov 21, 2023
FY2020 Sep 30, 2019 137.84M Nov 24, 2020
FY2019 Sep 30, 2018 145.64M Nov 26, 2019
FY2018 Sep 30, 2017 144.10M Nov 21, 2018
FY2017 Sep 30, 2016 141.54M Nov 22, 2017

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2021 Sep 30, 2021 $218.00M Nov 23, 2021
FY2021 Sep 30, 2020 $205.00M Nov 23, 2021
FY2021 Sep 30, 2019 $191.00M Nov 23, 2021
FY2020 Sep 30, 2018 $151.00M Nov 24, 2020
FY2019 Sep 30, 2017 $127.00M Nov 26, 2019
FY2018 Sep 30, 2016 $113.44M Nov 21, 2018
FY2017 Sep 30, 2015 $103.14M Nov 22, 2017
FY2016 Sep 30, 2014 $88.10M Nov 22, 2016
FY2015 Sep 30, 2013 $76.59M Nov 25, 2015
FY2014 Sep 30, 2012 $68.78M Nov 25, 2014